Abstract
Background: It has been suggested that genetic factors may be substantially linked to allergy disorders.
Objective: This study aims to investigate the relationship between the serum specific Immunoglobulin E (sIgE), blood eosinophil, and the polymorphisms of glycoprotein Ib alpha gene (GP1BA) rs6065, platelet endothelial aggregation receptor 1 gene (PEAR1) rs12041331, and plasminogen activator inhibitor 1 gene (PAI-1) rs1799762.
Methods: From the Peking Union Medical College Hospital, this study enrolled 60 healthy participants and 283 participants with allergic diseases. TaqMan-minor groove binder (MGB) quantitative polymerase chain reaction (qPCR) was used to examine the gene polymorphisms in each group.
Results: The TaqMan-MGB qPCR results were completely consistent with the DNA sequencing results, according to other studies in this medical center (Kappa =1, p <0.001). The GP1BA rs6065, PEAR1 rs12041331, and PAI-1 rs1799762 polymorphisms did not show different distribution between allergy patients and healthy individuals. Concerning allergy patients, the CT (n=33) genotype of GP1BA rs6065 had higher blood eosinophil level than the CC (n=250) genotype (0.59, IQR 0.32-0.72 vs 0.31, IQR 0.15-0.61, *109/L, p =0.005). The serum sIgE of AA (n=46) genotype of PEAR1 rs12041331 was lower (median 3.7, interquartile quartiles (IQR) 0.2-16.8, kU/L) than the GA (n=136) and GG (n=101) genotypes (GA median 16.3, IQR 3.1-46.3, kU/L, p = 0.002; GG median 12.9, IQR 3.0-46.9, kU/L, p =0.003). The GA genotypes of PEAR1 rs12041331were with higher blood eosinophil levels (median 0.42, IQR 0.17-0.74 *109/L) than the AA genotype (median 0.25, IQR 0.15-0.41*109/L, p =0.012). The sIgE of the 5G5G (n=44) genotype of PAI-1 rs1799762 was lower (median 5.0, IQR 0.1-22.8, kU/L) than the 4G5G (n=144) (median 17.3, IQR 3.7-46.0, kU/L, p = 0.012).
Conclusion: The GP1BA rs6065, PEAR1 rs12041331, and PAI-1 rs1799762 polymorphisms may be associated with the genetic susceptibility of serum sIgE or blood eosinophil in Chinese allergic disease patients.
Keywords: Allergy and immunology, gene polymorphism, platelet endothelial aggregation receptor 1 (PEAR1), specific immunoglobulin E (sIgE), eosinophil, glycoprotein Ib alpha gene (GP1BA), plasminogen activator inhibitor 1 gene (PAI-1).
[http://dx.doi.org/10.1159/000504364] [PMID: 31694018]
[http://dx.doi.org/10.3390/ijms22084130] [PMID: 33923629]
[http://dx.doi.org/10.1038/s41572-020-00227-0] [PMID: 33273461]
[http://dx.doi.org/10.3390/ijerph17124553] [PMID: 32599814]
[http://dx.doi.org/10.1111/all.15044] [PMID: 34379805]
[http://dx.doi.org/10.1016/j.envres.2021.112472] [PMID: 34863689]
[http://dx.doi.org/10.1111/all.14632] [PMID: 33068299]
[http://dx.doi.org/10.1016/j.jaci.2021.10.001] [PMID: 34655640]
[http://dx.doi.org/10.1111/pai.13443] [PMID: 33370488]
[http://dx.doi.org/10.1111/all.15089] [PMID: 34519063]
[http://dx.doi.org/10.3389/fped.2019.00251] [PMID: 31275911]
[http://dx.doi.org/10.1016/j.dld.2016.11.012] [PMID: 27979389]
[http://dx.doi.org/10.1097/ACI.0b013e328334f5fb] [PMID: 20010094]
[http://dx.doi.org/10.1111/exd.14602] [PMID: 35538735]
[http://dx.doi.org/10.1084/jem.20221755] [PMID: 36884218]
[http://dx.doi.org/10.1126/science.abj5117] [PMID: 35298243]
[http://dx.doi.org/10.1016/j.coi.2015.08.002] [PMID: 26386198]
[http://dx.doi.org/10.1111/1346-8138.12321] [PMID: 24628071]
[http://dx.doi.org/10.1007/164_2021_484] [PMID: 34085121]
[http://dx.doi.org/10.1016/j.iac.2021.01.010] [PMID: 33863485]
[http://dx.doi.org/10.3389/fmed.2020.588404] [PMID: 33469544]
[http://dx.doi.org/10.24953/turkjped.2023.389] [PMID: 37853967]
[http://dx.doi.org/10.1016/j.mayocp.2021.04.025] [PMID: 34538424]
[http://dx.doi.org/10.1016/j.jaci.2023.05.004] [PMID: 37201903]
[http://dx.doi.org/10.1186/s40779-022-00366-3] [PMID: 35093168]
[http://dx.doi.org/10.1089/ped.2022.0114] [PMID: 36473200]
[http://dx.doi.org/10.4193/Rhin18.292] [PMID: 31129685]
[http://dx.doi.org/10.1038/nri2273] [PMID: 18301424]
[http://dx.doi.org/10.1111/j.1398-9995.1999.tb04384.x] [PMID: 10422744]
[http://dx.doi.org/10.1016/j.humimm.2018.07.227] [PMID: 30036556]
[http://dx.doi.org/10.1371/journal.pone.0274951] [PMID: 36201519]
[http://dx.doi.org/10.3390/jcm12123963] [PMID: 37373658]
[http://dx.doi.org/10.1080/02770903.2016.1196371] [PMID: 27304223]
[http://dx.doi.org/10.1002/clt2.12239] [PMID: 37186423]
[http://dx.doi.org/10.1016/j.immuni.2021.08.009] [PMID: 34506733]
[http://dx.doi.org/10.1074/mcp.M114.046946] [PMID: 25713122]
[http://dx.doi.org/10.1111/j.1365-2222.2009.03272.x] [PMID: 19438580]
[http://dx.doi.org/10.1016/j.cgh.2020.09.040] [PMID: 33007513]
[http://dx.doi.org/10.15586/aei.v49i3.73] [PMID: 33938185]
[http://dx.doi.org/10.1016/j.ajpath.2021.04.003] [PMID: 33887217]
[http://dx.doi.org/10.2147/JAA.S371120] [PMID: 36034974]
[http://dx.doi.org/10.1186/s12959-022-00430-x] [PMID: 36376889]
[http://dx.doi.org/10.3389/fphar.2021.811719] [PMID: 35126146]
[http://dx.doi.org/10.3389/fgene.2023.1139813] [PMID: 36911417]
[http://dx.doi.org/10.1016/j.iac.2021.09.005] [PMID: 34823751]
[PMID: 32931210]
[http://dx.doi.org/10.1002/cti2.1435] [PMID: 36583159]
[http://dx.doi.org/10.1371/journal.pone.0034385] [PMID: 22479620]
[http://dx.doi.org/10.1034/j.1398-9995.2002.03582.x] [PMID: 11972486]
[http://dx.doi.org/10.1016/j.lfs.2013.05.023] [PMID: 23770230]
[http://dx.doi.org/10.1183/13993003.02288-2021] [PMID: 35210326]